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Beyond nutrients: Food-derived
microRNAs provide cross-kingdom
regulation
Mengxi Jiang1), Xiaolin Sang2) and Zhi Hong2)
Food turns out to be not only the nutrient supplier for
our body but also a carrier of regulatory information.
Interestingly, a recent study made the discovery that
some plant/food-derived microRNAs (miRNAs) accumu-
late in the serum of humans or plant-feeding animals, and
regulate mammalian gene expression in a sequence-
specific manner. The authors provided striking evidence
that miRNAs could function as active signaling molecules
to transport information across distinct species or even
kingdoms. Although the mechanism of how miRNAs are
shuttled between different organisms is still not well
characterized, initial results point to the involvement of
microvesicles and specific RNA-transporter-like proteins.
These findings raise both speculation about the potential
impact that plants may have on animal physiology at the
molecular level, and an appealing possibility that food-
derived miRNAs may offer us another means to deliver
necessary nutrients or therapeutics to our bodies.
Keywords:.cross-kingdom regulation; microRNA; microvesicle; RNA
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Introduction
The ecosystem in which we are living is inter-connected:
individual species are not isolated, but are associated with
each other. There is constant communication between all
living organisms, as well as between the organisms and their
habitat. Cells communicate with each other using common
signaling molecules such as hormones, cytokines, growth
factors, and second messengers. Recently, secreted
microRNAs (miRNAs) have emerged as novel signaling mol-
ecules to mediate intercellular communication [1–3]. miRNAs
are a class of 19–24-base-long nucleotides derived from the
primary miRNA hairpin portion of transcripts. They were first
characterized as non-coding RNAs from the nematode
Caenorhabditis elegans in 1993 [4, 5]. They are known to
function in a sequence-specific manner to silence specific
protein-coding genes at the post-transcriptional level by tar-
geting the 30 untranslated region (30 UTR) of mRNA [6]. Where
there is extensive complementary base pairing, miRNAs can
direct mRNA cleavage; often, where there is only partial
homology, miRNAs can lead to translational repression and
mRNA destabilization [6]. Using the recently developed deep-
sequencing technology, miRNAs have been found in a wide
spectrum of eukaryotes from plants to mammals, including
humans, algae, and viruses [7]. So far, over 15,000 miRNA
gene loci distributed over 140 species have been annotated in
the miRBase database [8]. With a rapid increase in knowledge
accumulated over the last decade, miRNAs are now recognized
as a crucial regulatory element that can manipulate various
biological processes including cell growth and differentiation,
development, apoptosis, and metabolism [9].
In mammals, miRNAs have recently been found in serum,
plasma, urine, saliva, and other body fluids [10–14].
Surprisingly, contrary to traditional beliefs on extracellular
RNA stability, biochemical analyses indicate that, in mam-
mals, these circulating miRNAs are highly stable and resistant
to RNase activity, as well as extreme pH and temperature [15, 16].
More importantly, it has been reported that the profiles of
circulating miRNAs, particularly serum miRNAs, are tightly
correlated with a variety of diseases, including cancer and
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diabetes, and with tissue injury. This suggests that miRNAs
could be used as biomarkers to diagnose and monitor human
diseases [15–23]. In this review, we focus on the findings of
Zhang et al. [24] that secreted miRNAs can function as signal-
ing molecules in a cross-kingdom manner.
miRNAs are selectively packaged into
microvesicles to transport information
from cell to cell
Despite numerous reports of the detection of secreted miRNAs,
the exact mechanisms of how these miRNAs are transported
and act as signaling molecules are not clear. They have been
implicated in stem cell function, hematopoiesis, and immune
regulation [3, 25–28]. Recently, several lines of evidence have
suggested that miRNAs are selectively packaged into micro-
vesicle (MV) compartments to function efficiently in mamma-
lian cells. MVs are membrane-covered vesicles and can be
released by various kinds of cells. Based on the mechanism
of formation and the intracellular origin, MVs may be divided
into shedding vesicles (SVs), which directly bud from the cell
surface, exosomes, which are derived from endosomal mem-
branes [29, 30], and apoptotic bodies in response to apoptotic
stimuli [31]. It is believed that being packed in MVs can help
miRNAs escape RNase digestion since treatment with deter-
gents, which destroy the lipid structure of vesicles, can lead to
the miRNA degradation [3]. This indicates that the vesicle
structure is critical for miRNA stability. Some miRNAs are
present at a relatively higher level in MVs than in the parental
cells [28, 32]. Furthermore, MVs have been shown to possess
specific types and levels of miRNAs compared to those found
overall in cells under various conditions, supporting the hy-
pothesis that the miRNA packaging process is a selective
rather than a random event. Recently, it was demonstrated
that miRNAs contained in exosomes are released through a
ceramide-dependent secretory machinery, and that these
secreted miRNAs can function in recipient cells. For example,
a tumor-suppressive miRNA can be transported between cells
via this secretory pathway and can produce cell growth inhi-
bition in recipient cells [1].
In addition to MVs, argonaute-2 (Ago2), a protein involved
in the RNA-induced silencing complex (RISC) [33], and high-
density lipoprotein (HDL) [34] have recently been proposed to
act as carriers of miRNAs. These proteins may provide alterna-
tive, non-vesicular means of transporting miRNAs between
cells.
miRNA/double-stranded RNA regulates
gene expression in a cross-kingdom
manner
Cross-kingdom regulation through miRNA/double-stranded
RNA (dsRNA) has been observed in many organisms and
engineered systems. The uptake of exogenous miRNA/
dsRNA often leads to an alteration of gene expression in
the recipient cells. For example, feeding nematode larvae with
Escherichia coli expressing target gene dsRNA can effectively
initiate RNA interference (RNAi) on the target mRNA, indicat-
ing that bacteria-derived dsRNA can regulate gene expression
in a higher organism [35]. In addition to C. elegans, many other
species, such as planaria or certain parasitic nematodes, have
the ability to take up environmental dsRNA into their cells [36, 37].
Similarly, feeding insects plants that express dsRNA may also
trigger RNAi [38]. For example, when cotton bollworm larvae
are fed on plant material expressing dsRNA targeting
CYP6AE14, whose gene product helps the insect to counteract
the deleterious cotton metabolite gossypol, the transcript level
of this gene is decreased and causes larval growth retardation
[39]. In mammals, miRNAs have been identified in both cow
milk and human breast milk [13, 14], suggesting a potential
route for inter-individual communication via miRNAs.
Another interesting example of miRNA cross-kingdom regu-
lation comes from the discovery that engineered E. coli
expressing short hairpin RNA (shRNA) against a mammalian
gene can induce cross-kingdom RNAi both in vivo and in vitro
[40]. These findings may provide the groundwork for future
design of RNAi-based therapies.
Cross-kingdom regulation via miRNA/dsRNA also comes
from the virus-host interplay. In plants and insects, host
cells can process viral dsRNA into small interfering RNAs
(siRNAs), which can be maintained and amplified later to
target parasitic RNA [41]. Certain animal cells can encode
their own miRNAs as a defense mechanism to fight off foreign
viral genomes [42]. On the other hand, many viruses are
known to encode suppressor proteins that can counter this
defense with RNA silencing [41]. For example, Lecellier et al.
showed that a cellular miRNA, miR-32, is able to effectively
inhibit the accumulation of retrovirus primate foamy virus
type 1 (PFV-1) in human cells. Tas, a protein encoded by
PFV-1, however, can suppress miR-32-mediated translation
inhibition [43].
Plant-derived miRNA may regulate
mammalian gene expression
In a recent publication by Zhang et al. [24], the authors
explored the function of plant-derived miRNAs as active sig-
naling molecules to mediate intercellular communication.
They demonstrated that mature single-stranded plant
miRNAs are present in both serum and tissues of mammals
that use plants such as rice as their food sources. Using state-
of-the-art Solexa sequencing and traditional quantitative RT-
PCR, with or without oxidation of small RNAs with periodate,
they were able to verify that the miRNAs detected are bona fide
plant miRNAs [24]. In addition, in a murine model, the authors
tested the hypothesis that the plant miRNAs accumulate in the
sera and tissue as a result of food intake. They showed that the
exogenous mature plant miRNAs in food can pass through
mouse gastrointestinal (GI) tract to reach the sera and organs.
Moreover, the authors identified the low-density lipoprotein
receptor adapter protein 1 (LDLRAP1) as a target for MIR168a, a
plant miRNA that was present at a relatively high level in
human sera. The presence of exogenous pre-MIR168a or ma-
ture MIR168a miRNA can significantly reduce LDLRAP1
protein level in culture. Furthermore, feeding mice with rice
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that produces MIR168a reduced the amount of LDLRAP1
protein in liver, which in turn resulted in an elevation of
the LDL level in mouse plasma. Both the decrease of
LDLRAP1 and the increase of LDL in plasma, however, could
be blocked by the addition of an anti-MIR168a antisense
oligonucleotide [24]. These elegantly executed experiments
not only confirm the role of circulating miRNAs in intercellular
communication, but also suggest that miRNAs can transport
and function in a cross-kingdom manner. A schematic sum-
mary of how food-derived miRNAs can regulate mammalian
gene expression is shown in Fig. 1.
For the plant-derived miRNAs to be taken up by the animal
body from food sources and eventually reach the end organs,
they must overcome numerous challenges. First, once in the
mammalian GI tract, the exogenous miRNAs face many
extreme conditions such as various enzymes, phagocytosis,
and a low pH environment. These unfavorable surroundings
require miRNAs to have stable structures to protect themselves
from degradation prior to being taken up into the recipient
cells. Plant miRNAs are methylated at the 20-hydroxyl group of
the 30-terminal nucleotide, which inhibits 30-end uridylation
and subsequent 30-to-50 exonuclease digestion [44]. Consistent
with this, plant miRNAs have a slower degradation rate com-
pared to their synthetic forms [24], suggesting that methyl-
ation indeed may contribute to the stability of plant miRNAs
in vivo.
Second, how does the plant miRNA pass through the GI
tract? One possible mechanism may be that the intestinal
epithelial cells can somehow take up plant miRNAs from food,
albeit the exact trafficking pathway of the plants miRNA from
the gut to these cells is not known. In C. elegans, a multispan
transmembrane protein, SID-1 (systemic RNAi deficient-1), is
believed to form a channel that could allow passive diffusion
of dsRNA [45]. The mammalian SID-1 homolog is able to
enhance siRNA uptake [45, 46]. SID-2 is another recently
identified transmembrane protein in C. elegans that is import-
ant for environmental RNAi [47]. In contrast to the ubiquitous
expression of SID-1, SID-2 is expressed in the intestine and is
localized to the luminal membrane; it is thought to mediate
the endocytosis of dsRNA from the lumen [47]. The presence of
an RNA transporter protein on the cell surface may also
provide a means for the plant miRNAs to be transported across
the intestinal lumen in mammals. However, there are several
gaps that need to be filled when trying to identify the potential
transporter proteins in mammalian cells for plant miRNAs.
Although SID-1/SID-2 proteins are capable of transporting pre-
miRNAs and single-strand RNA with hairpin structures [47, 48],
whether SID-like proteins are capable of delivering natural
plant pre-miRNAs or mature miRNAs still needs to be eval-
uated. It is worth noting that there is no direct evidence that
mammalian Dicer and Ago2, the two key enzymes for mature
miRNA biogenesis, can recognize natural plant pre-miRNAs
and liberate single-stranded mature miRNAs. However, at
least some of the plant miRNAs are known to be taken up
by mammalian cells in their mature single-stranded form [24],
raising the possibility that a receptor or transporter gene
specific for single-stranded RNA is present on mammalian
cell surface.
The final challenge is how the plant miRNAs get shuttled
from the initial cells that take up these molecules to the end
organs such as liver in mammals. Using fluorescently labeled
MVs and miRNAs, it was demonstrated that miRNAs packaged
Figure 1. A schematic view for the uptake of
food-derived miRNAs into human cells. Food
enters the gastrointestinal (GI) tract, where it is
digested, releasing small pieces of debris and
molecules that human cells can absorb, includ-
ing amino acids, fatty acids, and miRNAs.
Exogenous miRNAs may be taken up into the
epithelial cells lining intestine by SID-like trans-
porters and selectively packaged into MVs.
miRNAs are secreted into the circulatory system
enclosed in MVs, together with components of
the RISC. On reaching the final recipient cells in
organs such as liver, miRNAs are released and
regulate the target gene in a sequence-specific
manner. MV, microvesicle; MVB, multivesicular
body; SID, systemic RNAi deficient; ncRNA,
non-coding RNA; RISC, RNA-induced silencing
complex.
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in MVs can be delivered to downstream recipient cells and
regulate target genes in these cells [3, 24]. Zhang et al. [24] also
hypothesized that plant miRNAs in food could be transported
through a similar mechanism: intestinal epithelial cells take
up miRNAs, which are then packaged into MVs, to be released
into the circulatory system (Fig. 1). Consistent with this, more
than half of the MIR168a in the serum was in a MV-packaged
form [24].
On reaching the mammalian target cells, the plant miRNAs
also develop several strategies to guarantee their functions
within the cells. It turns out that MVs package not only
miRNAs, but possibly also protein components of the RISC
to ensure that packaged miRNAs are active [3, 24]. MIR168a
was found to be associated with Ago2 in the MVs from human
intestinal epithelial cells [24]. In addition, after being deliv-
ered to the target liver cells, MIR168a is still found to be
associated with Ago2 along with its target LDLRAP1 mRNA
[24]. These data also suggest that plant miRNAs are able to
utilize mammalian Ago2 to execute their function.
How do plant-derived miRNAs regulate their target mRNAs
in mammalian cells? Whereas plant miRNAs tend to be per-
fectly or nearly perfectly complementary to their target
sequence and induce mRNA cleavage, mammalian miRNAs
only possess partial homology to targets and often cause
translational repression [49]. The fact that MIR168a decreases
the LDLRAP1 protein level, but does not affect the mRNA level,
indicates that it behaves like a mammalian miRNA in liver
cells. It would be interesting to analyze other plant miRNA
regulation patterns in mammalian cells.
Speculations raised by miRNA-mediated
cross-kingdom regulation
With the discovery that the exogenous miRNAs or shRNAs
derived from plants or bacteria can regulate gene expression of
mammalian cells [24, 40], many issues (some related to our
daily lives) are raised. First, what is the scope and degree of
food-derived miRNAs on regulation of mammalian genes?
Solexa sequencing has revealed that there are approximately
30 plant miRNAs in sera from Chinese individuals [24]. What
are the mammalian targets (other than LDLRAP1) of these
miRNAs? Also, what are the potential effects of these food-
derived miRNAs on our metabolism and health? Initially, due
to the complexity of the physiology involved, a panel of organs
and potential targets need to be further examined in animal
models. It would also be interesting to extract the contribution
of individual miRNAs in regulating mammalian genes, for
example, using engineered bacteria expressing individual
plant miRNAs.
Second, this study implies that while we are consuming
food, we not only absorb its nutrients, but also inherit signal-
ing and regulatory information from these food sources. This
may have an impact on the future design of genetically engin-
eered plants or identification of active ingredients in certain
plants that have therapeutic effects. In fact, the success of
engineered bacteria expressing an shRNA specifically silenc-
ing a mammalian target gene in mice confirms the potential of
RNAi-based gene therapy [40]. In China, traditional herbs
have been used to cure various diseases for thousands of
years. Some researchers are dedicated to isolating the
active/functional components from herbs; however, these
components continue to mystify and elude us. The miRNAs
that are now being discovered may provide additional clues
for evaluating the active therapeutic components of herbs.
The fact that oral ingestion of plant-derived miRNA/sRNA
can regulate human metabolism and gene expression also
raises concerns on transgenic crops. For decades there have
been debates on the safety of transgenic food with regards to
human health and the environment. This profound discovery
by Zhang et al. [24] should make decision takers more cautious
when considering the issues that may arise from the consump-
tion of transgenic crops.
Lastly, if plant miRNAs could act in animal cells, is the
reverse scenario possible? That is, could mammalian miRNA
regulate gene expression in a plant cell? Preliminary studies
have shown animal-specific miRNAs can be detected in plant
cells cultured on the medium supplemented with dairy milk
(Prof. Jianqun Chen, personal communication). These pio-
neering studies may initiate a new level of understanding
of the co-evolutionary processes existing between the king-
doms of life.
Conclusions
By studying circulating miRNAs we are realising that these
molecules represent a novel class of signaling molecules for
intercellular communication. The discovery that plant-specific
miRNAs accumulate in the sera and regulate the gene expres-
sion of human or plant-feeding animals extends the function
of miRNAs. These could represent a cross-kingdom regulatory
signal. Food intake, possibly via the intestinal epithelia of the
GI tract, may represent a general pathway for ingestion of
food-derived or food-associated miRNAs. Food-derived
exogenous miRNAs may also be qualified as a novel nutrient
component, like vitamins and minerals, and may provide us
with a novel system to deliver therapeutic small RNAs into
animals. However, the exact processes of miRNA transport
through organisms and the mechanism of cross-kingdom gene
regulation are still unclear. Future studies examining the
trafficking pathway, the miRNA cross-kingdom recognition
and regulatory mechanism, and the extent of cross-kingdom
regulation are warranted.
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